Recent SEC filings
Insider and ownership filing tracker
Form 4 reports insider transactions. Schedule 13D and 13G filings report certain significant ownership positions. 13F reports institutional holdings when filed by an investment manager. Always open the original filing for context.
Company and financial overview
This is a data-generated overview, not a published Rithvik Chethan research rating. Figures use the latest usable company filing and may differ from vendor-calculated trailing metrics.
Financial performance charts
Annual values from SEC filings. Free cash flow is calculated as operating cash flow less capital expenditures.
Upcoming catalyst timeline
Review the Earnings tab for the expected date and estimates.
OWNERSHIP DOCUMENT
EMA, RSI, MACD, volume, structure, and key levels update after a completed daily candle.
How the research score works
The overall score is a weighted research judgment covering business quality, fundamental strength, growth catalysts, valuation, technical condition, and downside risk. A high score does not eliminate risk, and a low score does not guarantee poor performance.
Company overview
Aflac provides supplemental insurance products that pay cash benefits directly to policyholders for medical expenses not covered by primary health insurance, with a substantial business presence in both the United States and Japan.
Business model
The company earns revenue from insurance premiums for supplemental products including accident, cancer, and disability insurance, with its Japan operations representing a particularly significant and historically profitable portion of overall business.
Growth drivers
- Continued supplemental insurance product growth in the US
- Japan market product diversification and distribution expansion
- Digital sales channel growth
- New product category expansion
Competitive position
Aflac's strong brand recognition, built through decades of marketing investment including its recognizable duck mascot, combined with its dominant position in Japan's supplemental insurance market, give it a differentiated competitive position.
Risks
Japan represents a significant portion of earnings and carries currency translation risk along with a challenging low interest rate environment historically affecting investment income, and competition in supplemental insurance continues in both core markets.
Valuation
Aflac trades on a price to book basis typical of life and supplemental insurers, with its strong brand and consistent profitability supporting a reasonable valuation relative to peers.
Final view
Aflac's differentiated supplemental insurance model and strong brand recognition in both the US and Japan support a durable, consistent business. My view is favorable, with Japan currency and interest rate sensitivity being factors to monitor.
Overall rating: 74/100
This website and its analysis are provided for educational and informational purposes only. Nothing on this site constitutes financial, investment, legal, or tax advice, or an offer to buy or sell any security. Market data is provided by Finnhub and other third-party sources and may be delayed, incomplete, or inaccurate. The author may hold positions in securities discussed, and opinions may change without notice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial professional before making investment decisions.